EUVIMEDEUVIMED entdecken
Crossref

Enhanced Whole Tumor Cell-Based Vaccines by a RAFT and Protein Fusion Strategy for Tumor Immunotherapy

He Yang iD, Ruyan Feng, Xingyu Heng, Fangjian Shan, Yichen Wang, Lihua Yao, Sujian Wang, Gaojian Chen iD, Hong Chen iD

Biomacromolecules · 14.04.2025 · 26 (4) · 2690-2699

DOI: 10.1021/acs.biomac.5c00115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 21.03.2025. Verfasst von He Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials College of Chemistry, Chemical Engineering and Materials Scienc…. Hauptthemen laut MEDLINE: Cancer Vaccines, Immunotherapy, Melanoma, Experimental. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inactivated whole tumor cell-based vaccines (WTVs) are a promising strategy for tumor immunotherapy, but have exhibited limited antitumor effects clinically. Aiming at constructing enhanced WTVs, we developed glycopolymer-engineered WTVs (G-WTVs) using a Halo-Tag protein (HTP) fusion technique and reversible addition-fragmentation chain transfer (RAFT) polymerization. In our study, G-WTVs with varying molecular weights of glycopolymers were constructed. Compared to unmodified tumor cells, all G-WTVs effectively induced the polarization of macrophages toward the M1 phenotype and promoted the secretion of pro-inflammatory cytokines. This enhanced immune response was attributed to the improved interactions between G-WTVs and the macrophages. Among the G-WTVs, the medium molecular weight variant demonstrated the most pronounced enhancement of antitumor immune responses. Notably, the administration of optimized G-WTVs effectively inhibited the growth of B16 melanoma in mice. Our findings provide a new approach to enhance the antitumor efficacy of WTVs via cell membrane glycopolymer engineering, offering a promising strategy for tumor immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesImmunotherapyMelanoma, ExperimentalAnimalsMiceMice, Inbred C57BLCell Line, TumorHumansMacrophagesFemale

Substanzen

Cancer Vaccines

Autor:innen und Institutionen

  • State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials College of Chemistry, Chemical Engineering and Materials Science Soochow University, 199 Ren'ai Road, Suzhou, Jiangsu 215123, P. R. C…
  • School of Chemical and Environmental Engineering, Hunan Institute of Technology, Hengyang 421002, P. R. China.
  • Jiangsu Biosurf Biotech Co., Ltd., Suzhou 215123, P. R. China.

ORCID-Profile: He Yang, Gaojian Chen, Hong Chen

Förderung

  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

Yang, H., Feng, R., Heng, X., Shan, F., Wang, Y., Yao, L., Wang, S., Chen, G., & Chen, H. (2025). Enhanced Whole Tumor Cell-Based Vaccines by a RAFT and Protein Fusion Strategy for Tumor Immunotherapy. Biomacromolecules, 26(4), 2690-2699. https://doi.org/10.1021/acs.biomac.5c00115

Vancouver

Yang H, Feng R, Heng X, Shan F, Wang Y, Yao L, et al. Enhanced Whole Tumor Cell-Based Vaccines by a RAFT and Protein Fusion Strategy for Tumor Immunotherapy. Biomacromolecules. 2025;26(4):2690-2699. doi:10.1021/acs.biomac.5c00115

BibTeX
@article{Yang2025,
  author = {Yang, He and Feng, Ruyan and Heng, Xingyu and Shan, Fangjian and Wang, Yichen and Yao, Lihua and Wang, Sujian and Chen, Gaojian and Chen, Hong},
  title = {Enhanced Whole Tumor Cell-Based Vaccines by a RAFT and Protein Fusion Strategy for Tumor Immunotherapy},
  journal = {Biomacromolecules},
  year = {2025},
  volume = {26},
  number = {4},
  pages = {2690--2699},
  doi = {10.1021/acs.biomac.5c00115}
}
Kostenlos starten →